SCHEMBL6795782

SCHEMBL6795782

Cc1ccc(-c2ccccc2C(=O)Nc2ccc(CC(=O)O)cc2)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 3/20 0.67
NR1H4 Q96RI1 5/20 0.65
CHRNB2 P17787 1/20 0.58
CHRNB4 P30926 1/20 0.58
CHRNA3 P32297 1/20 0.58
CHRNA4 P43681 1/20 0.58
POLB P06746 1/20 0.55
GAA P10253 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
TP53 P04637 2/20 0.54
KMT2A Q03164 2/20 0.54
MEN1 O00255 1/20 0.54
GLA P06280 1/20 0.54
LMNA P02545 2/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
HSD17B10 Q99714 2/20 0.52
NPC1 O15118 1/20 0.52
NFKB1 P19838 1/20 0.52
HTT P42858 1/20 0.52
RAB9A P51151 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6239639 0.91 NR1H4 (0.73) FFAR1NR1H4CHRNB2CHRNB4CHRNA3
SCHEMBL31393753 0.86 CHRNB2 (0.78) CHRNB2CHRNB4CHRNA3CHRNA4POLB
SCHEMBL3729112 0.84 NR1H4 (0.58) FFAR1NR1H4CHRNB2CHRNB4CHRNA3
SCHEMBL7372972 0.83 CHRNB2 (0.63) CHRNB2CHRNB4CHRNA3CHRNA4POLB
SCHEMBL6793651 0.82 NPC1 (0.63) CHRNB2CHRNB4CHRNA3CHRNA4POLB
SCHEMBL6792355 0.81 KMT2A (0.59) CHRNB2CHRNB4CHRNA3CHRNA4KMT2A
Hydrochloric Acid SCHEMBL6801121 0.80 CHRNB2 (0.59) CHRNB2CHRNB4CHRNA3CHRNA4POLB
SCHEMBL6237411 0.80 GAA (0.60) FFAR1NR1H4CHRNB2CHRNB4CHRNA3
SCHEMBL7378480 0.79 BCAT2 (0.47) FFAR1NR1H4CHRNB2CHRNB4CHRNA3
SCHEMBL6788071 0.79 KDM4E (0.51) CHRNB2CHRNB4CHRNA3CHRNA4POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040058903-A1 Benzamide compounds as apo b secretion inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040058903-A1 Benzamide compounds as apo b secretion inhibitors APOB, APOL1, SCARB1 FFAR1 306/4885NR1H4 245/4885CHRNB2 1763/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.